We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Radio-frequency identification (RFID) use in the pharmaceutical industry is growing under state and federal mandates to secure the supply chain and prevent counterfeiting, but technology limitations and security weaknesses may slow full implementation, according to an ABI Research study, "The RFID Life Sciences Market," which looks at the driving forces behind adoption and RFID's benefits.
Eli Lilly is placing bar codes on individual vials of nine of its insulin products to ensure accurate dispensing to hospitalized patients, the company announced Feb. 7. The Indianapolis-based company had been including bar codes only on outer insulin packaging.
Sherwood Technology has been awarded a U.S. patent for a method of laser marking edible products — a process the company believes may be applicable to anticounterfeiting, product-tracking and process validation activities in the pharmaceutical industry.
In the wake of mounting concerns over drug safety, the FDA has started reviewing the possibility of building a new adverse event reporting system (AERS).
An exclusive licensing agreement between Quest Diagnostics and the University of Texas’ M. D. Anderson Cancer Center that grants Quest the use of five proprietary blood testing methods could lead to new blood tests for the diagnosis, treatment and monitoring of leukemia and lymphoma in cancer patients, the company announced.
HHS secretary-designate Mike Leavitt announced proposed regulations Jan. 27 that would facilitate the use of electronic prescriptions when the Medicare drug benefit takes effect next January.
Novartis’ breast cancer drug Femara may receive a boost from a new study that indicates the drug is more effective than traditional treatments such as tamoxifen.
The Good Automated Manufacturing Practice (GAMP) Forum, a division of the International Society for Pharmaceutical Engineering (ISPE), will release its “GAMP Good Practice Guide: Risk Management Approach to Electronic Records and Signatures,” on Feb. 18 at an ISPE conference in Tampa, Fla.
The new chairman of the Senate Health, Education, Labor and Pensions (HELP) Committee noted that a plan allowing importation of pharmaceuticals into the U.S. could conflict with the FDA’s mission, but he said that he would still support such legislation.
Israel-based medical device company Glucon Medical is planning to launch a noninvasive blood glucose monitoring device utilizing photoacoustic technology by 2007, which could signal an end to the standard finger-prick blood-testing technique used by diabetics.